Saint Petersburg State Pediatric Medical University of the Ministry of Healthcare of the Russian Federation ; Children’s City Clinical Hospital No. 5 named after N.F. Filatov
Auto-generated profile, based on publicly available information
Maria A. Shakmaeva
Saint Petersburg State Pediatric Medical University of the Ministry of Healthcare of the Russian Federation ; Children’s City Clinical Hospital No. 5 named after N.F. Filatov
The new coronavirus infection (COVID-1 9) is a socially significant problem around the world. According to available statistics, complications are less common among children, asymptomatic or mild forms of the disease prevail more often.This article presents the features of the viral landscape of the upper respiratory tract in children with ARVI in a pandemic, the clinical and laboratory features of the course of COVID-1 9 in children of different ages.It was found that SARS-CoV-2 is detected only in a third (32.9%) of hospitalized patients with respiratory symptoms, in 4.3% of cases — in combination with seasonal CoV-OC43 / CoV-229E, in 1 1.6% — with other respiratory viruses. The most frequent source of infection with the SARS-Cov-2 were family members. Children with a moderate form of the disease predominated among the patients. The leading symptoms of COVID-19 were fever, catarrhal symptoms, as well as gastrointestinal manifestations and anosmia. A feature of the new coronavirus infection in newborns and children of the first month of life was the absence of fever and intoxication, the lack of expression of catarrhal manifestations when the colon is involved in the pathological process (colitis, rarely — hemocolitis). In the compete blood test in children under the age of one year, monocytosis prevailed, in children over 7 years old — leukopenia and accelerated ESR. Among the changes in the biochemical analysis of blood, the most common was an increased C-reactive protein.
EBV-mononucleosis is a widespread infectious disease, and also it is an urgent problem of the whole world. The purpose of the research was to study the clinical and laboratory features of EBV-mononucleosis in hospitalized children of different ages in modern conditions. Under the supervision were 136 children aged from 1 year to 18 years. All of the patients had typical and mainly (85%) moderate form of the disease, and 15% of them patients had a severe form of the disease. The results: more severe fever and lymphadenopathy were observed in children older than 3 years. Acute tonsillitis was present in all hospitalized children. Adenoiditis and hepatosplenomegaly were greater in the group of patients of a younger age. Hyperfermentemia was determined in more than half of patients, more often in children over 12 years old. In the hemogram leukocytosis and monocytosis were mostly noted. Atypical blood mononuclear cells were detected in 89% of patients. Patients got complex etiopathogenetic therapy.
Children get sick less often than adults with a new coronavirus infection (in the Russian Federation, they account for 7.6% of registered cases of COVID-19), with less severe clinical symptoms, they require hospitalization less often, their disease is milder. The frequency of severe and extremely severe cases of COVID-19 in children does not exceed 1%. A clinical case of the course of COVID-19 in a child aged 2 years 4 months is presented. with acute lymphoblastic leukemia. A feature of the presented case is the development of an extremely severe new coronavirus infection in a child with secondary immunodeficiency caused by a long-term course of malignant, treatment-resistant of acute lymphoblastic leukemia. Slow, within 3 months, the development of the infectious process with long-term preservation of normal indicators of the function of the respiratory system led to the formation of viral-bacterial pneumonia with the development of respiratory distress syndrome. Despite the modern complex of therapeutic measures, severe comorbidity led to the development of DIC and multiple organ failure, which was the direct cause of the childs death. A possible therapy strategy is discussed in a patient with severe comorbidity against the background of secondary immunodeficiency and long-term persistence of SARS-CoV-2 in the presence of IgG antibodies to SARS-CoV-2 in the blood. For the first time, data on morphological changes in the lungs with a long course of COVID-19 (more than 100 days) in a young child are presented.
31 August 2022 in HIV Infection and Immunosuppressive Disorders
A new coronaviral infection in the Russian Federation is registered less in a child treatment than in an adult one. Children’s COVID-19 is mainly asymptomatic or in mild, severe form occurs rarely. The percentage of paediatric-age patients that require in-patient medical care is from 5,7% to 20% of children with COVID-19. However, clinical observations show that children’s COVID-19 may be severe and extremely severe, also resulting in death. A risk group of unsmooth course of the new coronaviral infection is patients with serious comorbide pathology, in particular oncohematological disease, passing radiation, chemotherapy, transplantation of hematopoietic stem cells. Acute lymphoblastic leukaemia, the most frequent paediatric-age oncological disease, may be one of the factors, predisposing to severe course of the new coronaviral infection. However, COVID-19 is likely to cause the deterioration of leukaemia treatment and an adverse outcome. The article presents a clinical observation of a 12-year-old child with a critical form of the new coronaviral infection and acute lymphoblastic leukaemia in the post-transplantation period. The accumulation of COVID-19 was accompanied by deterioration in the underlying disease. Despite high-quality medical care, using modern technologies, the child had progressive deterioration with a poor outcome.
Measles is one of the most highly contagious airborne infections. Those who are not vaccinated or have not been ill after contact become ill in almost 100% of cases. Objective: to evaluate the effectiveness of emergency measles prevention in children in a specialized institution with round-the-clock stay. Materials and methods: a retrospective analysis of a measles outbreak in a specialized psychoneurological children's home was conducted. Results: the zero patient was an unvaccinated girl aged 1 year 26 days, who had previously been treated in a hospital for COVID-19, where at the same time measles patients were being treated. She fell ill after 14 days, was re-hospitalized on the 17th day. On the same day, 171 contacts were identified, 7/5.3% of employees were revaccinated with a live measles monovalent vaccine, 10/41.7% of children over 12 months of age received a combined vaccine against measles, rubella and mumps and 14/58.3% of children under 12 months of age received normal human immunoglobulin was administered intramuscularly in 1 dose (1.5 ml). During the period of epidemiological observation, 8/33.3% of children who received emergency prophylaxis fell ill (1/10.0% — trivaccine and 7/50.0% — immunoglobulin). All suffered from typical measles of moderate severity. Conclusion. The development of the disease in 50.0% of cases with consistent involvement in the epidemic process after passive prophylaxis indicates insufficient effectiveness of the administration of the minimum recommended dose of immunoglobulin.